Cancer is oftentimes difficult to treat because tumors can stay hidden from the body’s own immune system. Immunotherapies are a new approach to cancer treatment in both human and veterinary medicine and are beginning to gain more support. Torigen’s novel vaccine technology uses a patient’s own tumor cells to create an immunotherapy. Most immunotherapies focus on studying only a tiny section of the tumor, but Torigen analyzes a much larger and more diverse sample of cancerous cells. This way, we can create a more effective treatment that targets a wider array of antigens.